Gene therapy firm Generation Bio lands $110 mln Series C
Cambridge, Massachusetts-based Generation Bio, a gene therapy company, has secured $110 million in Series C financing.
Cambridge, Massachusetts-based Generation Bio, a gene therapy company, has secured $110 million in Series C financing.
Copyright PEI Media
Not for publication, email or dissemination